Your browser doesn't support javascript.
loading
The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller, Suzanne; Henry, Amanda P; Hodge, Emily; Kheirallah, Alexander K; Billington, Charlotte K; Rimington, Tracy L; Bhaker, Sangita K; Obeidat, Ma'en; Melén, Erik; Merid, Simon K; Swan, Caroline; Gowland, Catherine; Nelson, Carl P; Stewart, Ceri E; Bolton, Charlotte E; Kilty, Iain; Malarstig, Anders; Parker, Stuart G; Moffatt, Miriam F; Wardlaw, Andrew J; Hall, Ian P; Sayers, Ian.
Afiliação
  • Miller S; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Henry AP; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Hodge E; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Kheirallah AK; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Billington CK; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Rimington TL; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Bhaker SK; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Obeidat M; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Melén E; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Merid SK; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Swan C; Department of Biology, University of York, York, United Kingdom.
  • Gowland C; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Nelson CP; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Stewart CE; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Bolton CE; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Kilty I; Pfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America.
  • Malarstig A; Pfizer Worldwide Research & Development, Cambridge, United Kingdom.
  • Parker SG; Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.
  • Moffatt MF; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Wardlaw AJ; Institute for Lung Health, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Hall IP; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Sayers I; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
PLoS One ; 11(10): e0164041, 2016.
Article em En | MEDLINE | ID: mdl-27755550
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fumar / Doença Pulmonar Obstrutiva Crônica / Receptor para Produtos Finais de Glicação Avançada / Pulmão Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fumar / Doença Pulmonar Obstrutiva Crônica / Receptor para Produtos Finais de Glicação Avançada / Pulmão Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido